NLARx News
New Hampshire House Passes NLARx
Member Rep. Rosenwald's Medical Records Privacy Act More
|
In the States
OHIO: Judge Fines J&J $4.75 Million
Over Misleading Materials Given to Doctors More
PENNSYLVANIA: State Launches Online Database
Of Retail Prescription Drug Prices More
MASSACHUSETTS: Health Panel Adopts Final Rules On Drug, Device Company Gifts to Providers More
Mylan Faces Medicaid Pricing Suit More
COLORADO: Gift Ban and Data Mining Bill Bites the Dust More
MICHIGAN: Democrats Again Trying to Change State's Prescription Drug Lawsuit Statute More
NEW JERSEY: Judge Denies Class Action Status for Consumers Seeking to Recoup Vioxx Costs More
State to Charge Medicaid Co-Pays More
NEW YORK: Drug Discount Program to Take Effect in April More
RHODE ISLAND: Governor's Budget Includes Cut in Prescription Drug Aid for the Elderly More
CONNECTICUT: Attorney General and Health Advocate Seek Ban On Drug Company Gifts to Doctors More
TEXAS: Legislators Consider a Series of Bills on PBMs, Mail Order More
KENTUCKY: Amgen Settles Kentucky Medicaid Lawsuit More |
Outrage of the Week
Top Scientist Fabricated Data in 21 Clinical Trials for Pain Killers More
|
Fraud & Abuse
Schering Pays $165m to Settle GMP Allegations More
AstraZeneca Accused of Suppressing Negative Seroquel Study More
|
Prices and Access to Healthcare
Biogenerics, Stem Cell Research Key To Curbing Health Costs, Sen. Hatch Says More
Walgreen Sees Customers Delaying Prescriptions More
Slowing the Growth of Health Care Costs - Lessons from Regional Variation More
Kaiser Family Foundation Issues Updated Primer on Health Care Costs More
Glaxo Cuts Drug Prices in Poor Countries More |
Reimportation
Senate Bill May Allow Overseas Prescription Imports More
Drug Importation on Lawmakers' Agenda More
|
Executive Branch Appointments
Obama FDA Picks Raise Some Hackles More
Obama Names David Blumenthal Head of Health Information Technology More
HHS Names Panel of 15 Experts To Advise Government on Spending for Comparative Effectiveness Research More
|
Pharma Watch
Drug Sales Eke Out 1.3% Growth in 2008 More
Roche and Genentech Reach Merger Agreement More
Amid Merger Frenzy, Some Are Second-Guessing More
What's Driving Drug Mergers? More
Big Drug Deals Mean Big Risks More
Pfizer Aims to Grow Generically More
Big Pharma Eyes Rural India for Growth More
What's the Cause of the Drug Industry's Bad Reputation? More
Pharma Eavesdrops on Doctors Online More
Bristol-Myers CEO Comp. Tops $21 Million More
J&J chief paid $23M; Amgen's got $14.5M More
Abbott Paid CEO Miles White $28.3 Million in 2008 More
|
Advertising and Marketing
Expert Predicts Sunshine Act Will Pass in 2009 More
New Privacy Rules in Economic Stimulus Law Will Restrict Certain Pharmaceutical Marketing Practices More
Pharma Media Spending Falls 18.4 Percent in 2008 More
Glaxo Expands List of Public Payments to Doctors More
Doctors Increasingly Close Doors to Drug Reps, While Pharma Cuts Ranks More
The Long Decline of Drug Sales Reps More
Pharma Reps Between Rock and a Hard Place More
That's Final: Massachusetts Gift Ban Rules Set More
Botox Rivals Could Fuel Big DTC Fight More
Pharma Reps' Worst Fear Is Near: Outsourced to the Internet! More
Pharma Dreams of Dipping Its Toe Into Social Networking Waters More
|
Conflicts of Interest
Harvard Doctor Promised J&J 'Positive' Trial Data More
Journal of the American Medical Association Instituting New Policy for
Those Submitting Conflicts-of-Interest Complaints More
New JAMA Policy Says Whistle-Blowers Should Stay Silent During Conflict-of-Interest Investigations More
Council on Ethical and Judicial Affairs Removes AMA Report on Conflicts of Interest from Website More
Cornell's Medical College Pays $2.6-Million in Federal Fraud Case More
Medical Schools Pressed To Cut Drug-Firm Ties More
|
PBM Watch
Change to Win Warns that CVS Caremark May be Violating Privacy of Hundreds of Thousands of New Jersey Workers More
Advocacy Group Warns NJ Patients About Possible CVS Caremark Privacy Issue More
Labor Coalition Sues Michigan College
In Effort to Obtain Rx Benefit Plan Data More
|
Medicare
Are Medicare Beneficiaries Choosing Low-Cost Plans for Part D? More
Seniors' Choice on Medicare Part D Often Not Cost-Based More
Proposal to Restructure and Improve Counseling and Education for Medicare Consumers More
|
Medicaid
President Obama's Budget Would Extend Drug Rebates to Medicaid Health Plans More
Maryland Legislation to Crack Down on Medicaid Fraud Beaten by Industry Opposition More |
Patents and Generics
Bipartisan House Group Sponsors Bill
To Create Pathway for Generic Biotech Drugs More
Biotechnology Industry Organization Statement on House Biogenerics Bill More
Rep. Eshoo Introduces Follow-on Biologics Bill More
Bill Offers 12 Years of Market Exclusivity More
Ruling on Patent Measures Deals Setback to Drug Firms More
Abbott Sues Mylan in AIDS Drug Patent Dispute More
Merck Grants License for Malaria Drug More
Europe's Patent Officials Target 'Evergreening' More
Drug Giants Urged to Create Patent Pools for Medicines for World's Poor More
|
Safety and Clinical Trials
Comparative Effectiveness Research: Coming Soon? More
Antidepressant Use Tied to Cardiac Death in Women More
Roche's Actemra Linked to 15 Deaths More
Off-Label Provigil Might Be Addictive More
Unpublished Study Links Seroquel to Weight Gain, Diabetes More
Grand Jury Probes Merck's Vioxx Activities More
Protocol Breach Reported in Biederman Study of Preschoolers More
Drugmakers Feel Impact of Preemption Ruling More
Drug Industry Research: Reliable or Not? More
Pharma Types 'Nervous' About New FDA Chief Sharfstein More
Some Drug Industry Advocates Want FDA Split More
FDA Cites "Objectionable Conditions" at Genzyme Plant More
How Drug Companies Use Social Networks to Recruit Patients for Clinical Research More |
